Pulmonary and peritoneal tuberculosis associated with tumor necrosis factor-alpha inhibitor use: A case report and review of the literature

Authors

Niharika Tipirneni, George Washington University
Marc O. Siegel, George Washington University

Document Type

Journal Article

Publication Date

2012

Journal

Case Reports in Pulmonology

Inclusive Pages

Article ID 598634

Abstract

The association between the use of tumor necrosis factor-α inhibitors and the increased risk of granulomatous infections, especially tuberculosis, has been well documented. Given the rapidly expanding list of inflammatory conditions for which tumor necrosis factor-α inhibitors are receiving FDA approval, the incidence of tuberculosis in this patient population has increased. Despite heightened awareness by physicians, the diagnosis of tuberculosis can remain challenging, given that extrapulmonary sites of infection are more frequently involved. We present a case of pulmonary and peritoneal tuberculosis in a gentleman being treated with a tumor necrosis factor-α inhibitor and discuss the diagnostic challenges of establishing the diagnosis.

Comments

Reproduced with permission of Hindawi Publishing Corp., Case Reports in Pulmonology.

Creative Commons License

This work is licensed under a Creative Commons Attribution 3.0 License.

APA Citation

Tipirneni, N., Siegel, M.O. (2012). Pulmonary and peritoneal tuberculosis associated with tumor necrosis factor-alpha inhibitor use: A case report and review of the literature. Case Reports in Pulmonology, 598634.

Peer Reviewed

1

Open Access

1